Ron Price
Net Worth
Last updated:
What is Ron Price net worth?
The estimated net worth of Mr. Ron Price is at least $1,190,126 as of 22 Apr 2022. He owns shares worth $1,381 as insider, has earned $62,595 from insider trading and has received compensation worth at least $1,126,150 in Accelerate Diagnostics, Inc..
What is the salary of Ron Price?
Mr. Ron Price salary is $225,230 per year as Chief Commercial Officer of Americas in Accelerate Diagnostics, Inc..
How old is Ron Price?
Mr. Ron Price is 61 years old, born in 1964.
What stocks does Ron Price currently own?
As insider, Mr. Ron Price owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Accelerate Diagnostics, Inc. (AXDX) | Chief Commercial Officer of Americas | 40,610 | $0.03 | $1,381 |
What does Accelerate Diagnostics, Inc. do?
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Ron Price insider trading
Accelerate Diagnostics, Inc.
Mr. Ron Price has made 3 insider trades between 2020-2022, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 40,755 units of AXDX stock on 21 Apr 2022. As of 22 Apr 2022 he still owns at least 40,610 units of AXDX stock.
Accelerate Diagnostics key executives
Accelerate Diagnostics, Inc. executives and other stock owners filed with the SEC:
- Mr. Jack Phillips (59) Chief Executive Officer, Pres & Director
- Mr. Lawrence Mehren (59) Advisor
- Mr. Ron Price (61) Chief Commercial Officer of Americas
- Mr. Steve Reichling (47) Chief Financial Officer, Chief Accounting Officer & Sec.